evinacumab
Selected indexed studies
- Evinacumab. (, 2006) [PMID:36153938]
- Evinacumab for Homozygous Familial Hypercholesterolemia. (N Engl J Med, 2020) [PMID:32813947]
- Evinacumab. (, 2012) [PMID:34292698]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Evinacumab. (2006) pubmed
- Evinacumab for Homozygous Familial Hypercholesterolemia. (2020) pubmed
- Evinacumab. (2012) pubmed
- Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy. (2024) pubmed
- Evinacumab: First Approval. (2021) pubmed
- Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia. (2024) pubmed
- Evinacumab in Patients with Refractory Hypercholesterolemia. (2020) pubmed
- Evinacumab: Mechanism of action, clinical, and translational science. (2024) pubmed
- Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. (2022) pubmed
- Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia. (2024) pubmed